Natalia Buza MD

Assistant Professor of Pathology; Associate Director of Gynecologic Pathology

Research Interests

Diagnostic and prognostic markers in endometrial, ovarian and breast cancer


Selected Publications

  • Buza N, English DP, Santin AD, Hui P. Toward Standard HER2 Testing of Endometrial Serous Carcinoma: Four-Year Experience At A Large Academic Center and Recommendations for Clinical Practice. Mod Pathol, 2013 Jun 14. doi: 10.1038/modpathol.2013.113. [Epub ahead of print]
  • Buza N, Hui P. Partial Hydatidiform Mole: Histological Parameters in Correlation with DNA Genotyping. Int J Gynecol Pathol, 2013 Mar 19. [Epub ahead of print]
  • Buza N. Chapter 5: Partial hydatidiform mole. In: Histology and Molecular Genetic Pathology of Gestational Trophoblastic Disease. Ed.: Pei Hui, Springer, New York, NY, 2011.
  • Buza N, Hui P. New diagnostic modalities in the histopathological diagnosis of hydatidiform moles. Diagn Histopathol. May 2012, 18(5):201-209.
  • Buza N, Zekry N, Charpin C, Tavassoli FA. Myoepithelial carcinoma of the breast: a clinicopathological and immunohistochemical study of 15 diagnostically challenging cases. Virchows Arch. 2010 Sep;457(3):337-45. Epub 2010 Jul 24.
  • Zhao S, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Landscape of Somatic Single Nucleotide and Copy Number Mutations in Uterine Serous Carcinoma. Proc Natl Acad Sci USA, 2013 Jan 28. [Epub ahead of print]
  • Richter CE, Hui P, Buza N, Silasi DA, Azodi M, Santin AD, Schwartz PE, Rutherford TJ. HER-2/NEU overexpression in vulvar Paget disease: the Yale experience. J Clin Pathol. 2010 Jun;63(6):544-7. Epub 2010 Apr 23.
  • Buza N, Cohen P, Hui P, Parkash V. Inverse p16 and p63 Expression in Small Cell Carcinoma and High Grade Urothelial Cell Carcinoma of the Urinary Bladder. Int J Sug Pathol, 2010, 18(2):94-102.
  • Cocco E, Hu Z, Richter CE, Bellone S, Casagrande F, Bellone M, Todeschini P, Krikun G, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Buza N, Pecorelli S, Lockwood CJ, Santin AD. hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma. Br J Cancer. 2010 Sep 7;103(6):812-9. Epub 2010 Aug 10.
  • Buza N, Tavassoli FA. Comparative analysis of p16 and p53 expression in uterine malignant mixed mullerian tumors. Int J Gynecol Pathol. 2009;28:514-21.

Edit Profile